For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Drug Screening Market valued approximately USD 4.9 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2017-2025. Driven by increasing consumption of drug & alcohol, stringent regulations mandating drug and alcohol testing the global drug increasing market is witnessing various opportunities over the forecast period. Furthermore, government funding and novel product development are anticipated to compel positive growth in the market.

The global drug screening market is segmented by product & services, sample type, and end-use. On the basis of the end-user segment, the market is segmented into workplaces, criminal justice systems and law enforcement, drug treatment centers, pain management centers, schools and colleges, hospitals, individual users, and drug testing laboratories. Currently, the market is dominated by workplace drug testing segment. Increasing awareness among organizations for regular drug testing and rising safety concerns at both corporate and industrial workplace is primarily driving the growth of this segment. Schools and colleges end-user segment are anticipated to grow at a significant rate over the forecast period.

Global Drug Screening MarketThe objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product & Service:

  • Drug Screening Product
    • Analytical Instruments
    • Rapid Testing Devices
  • Drug Screen Services

By Sample Type:

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By End-Use:

  • Workplace
  • Criminals Justice Systems & Law Enforcement Agencies (CJSALEA)
  • Drug Treatments Centre
  • Pain Management Centre
  • Schools & Colleges
  • Hospitals
  • Individual Users
  • Drug Testing Laboratories

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market Alere, Thermo Fisher Scientific

Dragewerk , LabCorp, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD Inc., Orasure

Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, Siemens Healthineers Frequent cross-industry partnerships are leading to market consolidation.

Target Audience of the Global Drug Screening Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.            Global Drug Screening Market Definition and Scope

1.1.         Research Objective

1.2.         Market Definition

1.3.         Scope of The Study

1.4.         Years Considered for The Study

1.5.         Currency Conversion Rates

1.6.         Report Limitation

Chapter 2.            Research Methodology

2.1.         Research Process

2.1.1.      Data Mining

2.1.2.      Analysis

2.1.3.      Market Estimation

2.1.4.      Validation

2.1.5.      Publishing

2.2.         Research Assumption

Chapter 3.            Executive Summary

3.1.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2.         Key Trends

Chapter 4.            Global Drug Screening Market Dynamics

4.1.         Growth Prospects

4.1.1.      Drivers

4.1.2.      Restraints

4.1.3.      Opportunities

4.2.         Industry Analysis

4.2.1.      Porter’s 5 Force Model

4.2.2.      PEST Analysis

4.2.3.      Value Chain Analysis

4.3.         Analyst Recommendation & Conclusion

Chapter 5.            Global Drug Screening Market, By Product & Service

5.1.         Market Snapshot

5.2.         Market Performance – Potential Model

5.3.         Global Drug Screening Market, Sub Segment Analysis

5.3.1.      Drug Screening Products

5.3.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.3.   Drug Screening Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.3.1.               Analytical Instruments

5.3.1.3.2.               Rapid Testing Devices

5.3.1.3.3.               Consumables

5.3.2.      Drug Screening Services

5.3.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6.            Global Drug Screening Market, By Sample Type

6.1.         Market Snapshot

6.2.         Market Performance – Potential Model

6.3.         Global Drug Screening Market, Sub Segment Analysis

6.3.1.      Urine Samples

6.3.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.      Breath Samples

6.3.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.      Oral Fluid Samples

6.3.3.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.      Hair Samples

6.3.4.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.      Other Samples

6.3.5.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.5.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7.            Global Drug Screening Market, By End-Use

7.1.         Market Snapshot

7.2.         Market Performance – Potential Model

7.3.         Global Drug Screening Market, Sub Segment Analysis

7.3.1.      Workplace

7.3.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.      Criminals Justice Systems & Law Enforcement Agencies

7.3.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.      Drug Treatment Centre

7.3.3.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.      Pain Management Centres

7.3.4.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.4.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.      Schools & Colleges

7.3.5.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.5.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.      Hospitals

7.3.6.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.6.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.      Individual Users

7.3.7.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.7.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.8.      Drug Testing Laboratories

7.3.8.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.8.2.   Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 

Chapter 8.            Global Drug Screening Market, by Regional Analysis

8.1.         Drug Screening Market, Regional Market Snapshot (2015-2025)

8.2.         North America Drug Screening Market Snapshot

8.2.1.      U.S.

8.2.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.      Canada

8.2.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.         Europe Drug Screening Market Snapshot

8.3.1.      U.K.

8.3.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.      Germany

8.3.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.      France

8.3.3.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.      Rest of Europe

8.3.4.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.         Asia Drug Screening Market Snapshot

8.4.1.      China

8.4.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.      India

8.4.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.      Japan

8.4.3.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.      Rest of Asia Pacific

8.4.4.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.         Latin America Drug Screening Market Snapshot

8.5.1.      Brazil

8.5.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.      Mexico

8.5.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.         Rest of The World

8.6.1.      South America

8.6.1.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.      Middle East and Africa

8.6.2.1.   Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2.   Product & Service breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3.   Sample Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4.   End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9.            Competitive Intelligence

9.1.         Company Market Share (Subject to Data Availability)

9.2.         Top Market Strategies

9.3.         Company Profiles

9.3.1.      Alere

9.3.1.1.   Overview

9.3.1.2.   Financial (Subject to Data Availability)

9.3.1.3.   Product Summary

9.3.1.4.   Recent Developments

9.3.2.      Alfa Scientific Designs

9.3.3.     Dragewerk

9.3.4.      Labcorp

9.3.5.      Lifeloc

9.3.6.      MPD Inc.

9.3.7.      Omega Laboratories

9.3.8.      Orasure

9.3.9.      Premier Biotech

9.3.10.    Psychemedics

9.3.11.    Quest Diagnostic

9.3.12.    Roche

9.3.13.    Shimadzu

9.3.14.    Siemens Healthineers

9.3.15.    Thermo Fisher Scientific

 

 

 

 

 

 

 

 

The research for Global Drug Screening Market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand across various end-use such as Schools & Colleges, Workplace, Pain Management Center, Hospitals and others.

The revenue for Global Drug Screening Market is calculated as sum market sizes of different segments such as end-use and regions. The market revenue is calculated by bottom up approach, thereby summing up the revenues from various products & services. Further, some other key data points considered to calculate the revenue for Global Drug Screening Market include:

  • Revenues from key companies
  • Key company market share analysis
  • Consumer spending analysis
  • Sales revenue generated by various applications in different geographies

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts. 


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,150

Enterprise License – $5,550


Loading…